TITLE

Alvine Brings in Another $21M for Celiac Studies

PUB. DATE
September 2009
SOURCE
Bioworld Week;9/21/2009, Vol. 17 Issue 38, p3
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article reports on the additional fund provided by Alvin Pharmaceuticals Inc. on the studies conducted regarding celiac disease in the U.S. It states that Alvin has gathered more funds to proceed on the Phase II trial of their celiac studies. It adds that the research will determine the effectiveness of protease therapy AVL003 in treating the most common hereditary autoimmune diseases in the country.
ACCESSION #
44369830

 

Related Articles

  • Alvine Brings in Another $21M to Fund Celiac Disease Studies. Harris, Glen // BioWorld Today;9/16/2009, Vol. 20 Issue 178, p1 

    The article reports on the funding for a study of celiac disease by Alvine Pharmaceuticals Inc. The fund will be used for the Phase IIa further development of the drug protease therapy AVL003 in the treatment of celiac disease. Celiac disease is a commonly inherited autoimmune disease caused by...

  • Primary hepatic anaplastic large cell ki-1 lymphoma and celiac disease: a casual association? Fuertes, Montiel Jiménez; Navarro, David Costa; Montalvá Orón, Eva Ma; López-Andújar, Rafael; Juan Burgueño, Manuel de; Pallardó, José Mir // Journal of Gastrointestinal Oncology;Mar2013, Vol. 4 Issue 1, p109 

    The article presents a case study of a 55-year-old man who was diagnosed with adult celiac disease. It notes that a primary hepatic anaplastic large T-cell ki-1 non-Hodgkin lymphoma has been identified after further medical screening. The article also discusses the treatment cases for primary...

  • Alvine and Dandy: Option Deal Brings $70M AbbVie Up Front. Osborne, Randy // BioWorld Today;5/15/2013, Vol. 24 Issue 93, p1 

    The article reports that the 70 million U.S. dollar up front from AbbVine Inc. buys an option for the firm to acquire ALV003, a drug candidate for celiac disease developed by Alvine Pharmaceuticals Inc. or the company itself. It reports that the Phase IIb trials for ALV003, a two-enzyme combo...

  • WHEN SHOULD ENDOCRINOLOGISTS THINK OF CELIAC DISEASE IN CHILDREN? Oana, Belei; Otilia, Marginean; Giorgiana, Brad; Camelia, Daescu // Jurnalul Pediatrului;Jul-Sep2013, Vol. 16 Issue 63, p14 

    Background: Recent researches proved that classical definition of celiac disease (CD) comprises only 30% of cases with genetic predisposition, the vast majority of patients being pauci-symptomatic. Active-case finding in groups at risk for CD is considered a cost/effective strategy. The...

  • An autosomal genome-wide screen for celiac disease in Bedouin families. Ding, Y. C.; Weizman, Z.; Yerushalmi, B.; Elbedour, K.; Garner, C. P.; Neuhausen, S. L. // Genes & Immunity;Jan2008, Vol. 9 Issue 1, p81 

    Celiac disease is a common, familial autoimmune disease caused by exposure to gliadin in wheat, and related prolamins in barley and rye. The prevalence of the disease is approximately 1:133. Celiac disease can cause significant morbidity. The only treatment is a gluten-free diet. A genome-wide...

  • COELIAC UK ANNOUNCES FOURFOLD INCREASE IN THE RATE OF DIAGNOSED CASES OF COELIAC DISEASE.  // Caterer & Hotelkeeper;5/16/2014, Vol. 203 Issue 4826, p46 

    The article discusses research being done on the rate of diagnosed cases of celiac disease in Great Britain. It references a study by Joe West published in an issue of "The American Journal of Gastroenterology." The research reveals a fourfold increase in the number of people who are diagnosed...

  • Accurate and Robust Genomic Prediction of Celiac Disease Using Statistical Learning. Abraham, Gad; Tye-Din, Jason A.; Bhalala, Oneil G.; Kowalczyk, Adam; Zobel, Justin; Inouye, Michael // PLoS Genetics;Feb2014, Vol. 10 Issue 2, p1 

    Practical application of genomic-based risk stratification to clinical diagnosis is appealing yet performance varies widely depending on the disease and genomic risk score (GRS) method. Celiac disease (CD), a common immune-mediated illness, is strongly genetically determined and requires...

  • Research.  // GIG Newsletter;Winter2011, Vol. 34 Issue 1, p41 

    This section offers news briefs on celiac disease. Researchers use an electronic tongue to detect gliadins in food. Researchers are studying the connection between celiac disease (CD) and autoimmune rheumatologic conditions. A study suggests that pediatric celiac patients should also be screened...

  • IgA Anti-transglutaminase Autoantibodies at Type 1 Diabetes Onset Are Less Frequent in Adult Patients and Are Associated With a General Celiac-Specific Lower Immune Response in Comparison With Nondiabetic Celiac Patients at Diagnosis. Tiberti, Claudio; Panimolle, Francesca; Bonamico, Margherita; Shashaj, Blegina; Filardi, Tiziana; Lucantoni, Federica; Nenna, Raffaella; Costantino, Francesco; Lenzi, Andrea; Morano, Susanna // Diabetes Care;Oct2012, Vol. 35 Issue 10, p2083 

    OBJECTIVE--To evaluate the celiac-associated humoral autoimmunity in child, adolescent, and adult patients at type 1 diabetes (DM1) onset and to determine whether DM1 celiac-specific humoral immunoreactivity occurs similarly to that in nondiabetic patients at celiac disease (CD) diagnosis....

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics